Characterisation of the endogenous human peripheral serotonin transporter SLC6A4 reveals surface expression without N-glycosylation

Journal of Neuroimmunology

Volumn 204, Issue 1-2, 2008, Pages 75-84

  Chamba, Anita ^a   Holder, Michelle J ^a   Barnes, Nicholas M ^a   Gordon, John ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Glycosylation; Lymphocytes; Serotonin transporter

Indexed keywords

SEROTONIN TRANSPORTER;

AMINO ACID SEQUENCE; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC TRANSFECTION; GLYCOSYLATION; HUMAN; HUMAN CELL; LYMPHOID CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

BIOTINYLATION; CELL LINE; DISACCHARIDES; GALACTOSAMINE; GENE EXPRESSION; GLYCOSYLATION; HUMANS; LYMPHOCYTES; MOLECULAR WEIGHT; PEPTIDE-N4-(N-ACETYL-BETA-GLUCOSAMINYL) ASPARAGINE AMIDASE; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRANSFECTION;

EID: 54349088443     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.07.014     Document Type: Article

References (56)

1. Balkovetz D.F., Tiruppathi C., Leibach F.H., Mahesh V.B., and Ganapathy V. Evidence for an imipramine-sensitive serotonin transporter in human placental brush-border membranes. J. Biol. Chem. 264 (1989) 2195-2198
2. Barkan T., Gurwitz D., Levy G., Weizman A., and Rehavi M. Biochemical and pharmacological characterization of the serotonin transporter in human peripheral blood lymphocytes. Eur. Neuropsychopharmacol. 14 (2004) 237-243
3. Belous A.R., Ramamoorthy S., Blakely R.D., Factor M.I., Dupin A.M., Katasonov A.B., Lozier R.H., Beniashvili A.G., Morozova M.A., and Brusov O.S. The state of the serotonin transporter protein in the platelets of patients with somatoform [correction of somatiform] disorders. Neurosci. Behav. Physiol. 31 (2001) 185-189
4. Bian X., Patel B., Dai X., Galligan J.J., and Swain G. High mucosal serotonin availability in neonatal guinea pig ileum is associated with low serotonin transporter expression. Gastroenterology 132 (2007) 2438-2447
5. Bliziotes M., Eshleman A., Burt-Pichat B., Zhang X.W., Hashimoto J., Wiren K., and Chenu C. Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells. Bone 39 (2006) 1313-1321
6. Cai G., Salonikidis P.S., Fei J., Schwarz W., Schulein R., Reutter W., and Fan H. The role of N-glycosylation in the stability, trafficking and GABA-uptake of GABA-transporter 1. Terminal N-glycans facilitate efficient GABA-uptake activity of the GABA transporter. FEBS J. 272 (2005) 1625-1638
7. Dmitriev A.D., Pavlova E.V., Factor M.I., Segal O.L., Massino Y.S., Dobrohotov I.V., Smirnova M.B., Hwun D.E., Yakovleva D.A., Kolyaskina G.I., and Brusov O.S. Analysis of serotonin transporter in human platelets by immunoblotting using site-specific antibodies. Biochemistry (Mosc.) 69 (2004) 629-641
8. Faraj B.A., Olkowski Z.L., and Jackson R.T. Expression of a high-affinity serotonin transporter in human lymphocytes. Int. J. Immunopharmacol. 16 (1994) 561-567
9. Frankhauser P., Grimmer Y., Bugert P., Deuschle M., Schmidt M., and Schloss P. Characterization of the neuronal dopamine transporter DAT in human blood platelets. Neurosci. Lett. 399 (2006) 197-201
10. Gordon J., and Barnes N.M. Lymphocytes transport serotonin and dopamine: agony or ecstasy?. Trends Immunol. 24 (2003) 438-443
11. Hirano K., Seki T., Sakai N., Kato Y., Hashimoto H., Uchida S., and Yamada S. Effects of continuous administration of paroxetine on ligand binding site and expression of serotonin transporter protein in mouse brain. Brain Res. 1053 (2005) 154-161
12. Hranilovic D., Herak-Kramberger C.M., Cicin-Sain L., Sabolic I., and Jernej B. Serotonin transporter in rat platelets. Level of protein expression underlies inherited differences in uptake kinetics. Life Sci. 69 (2001) 59-65
13. Iceta R., Mesonero J.E., Aramayona J.J., and Alcalde A.I. Molecular characterization and intracellular regulation of the human serotonin transporter in Caco-2 cells. J. Physiol. Pharmacol. 57 (2006) 119-130
14. Jayanthi L.D., Samuvel D.J., Blakely R.D., and Ramamoorthy S. Evidence for biphasic effects of protein kinase C on serotonin transporter function, endocytosis, and phosphorylation. Mol. Pharmacol. 67 (2005) 2077-2087
15. Jess U., Betz H., and Schloss P. The membrane-bound rat serotonin transporter, SERT1, is an oligomeric protein. FEBS Lett. 394 (1996) 44-46
16. Keynan S., Suh Y.J., Kanner B.I., and Rudnick G. Expression of a cloned gamma-aminobutyric acid transporter in mammalian cells. Biochemistry 31 (1992) 1974-1979
17. Krajewski S., Zapata J.M., and Reed J.C. Detection of multiple antigens on western blots. Anal. Biochem. 236 (1996) 221-228
18. Launay J.M., Geoffroy C., Mutel V., Buckle M., Cesura A., Alouf J.E., and Da Prada M. One-step purification of the serotonin transporter located at the human platelet plasma membrane. J. Biol. Chem. 267 (1992) 11344-11351
19. Lesch K.P., Wolozin B.L., Estler H.C., Murphy D.L., and Riederer P. Isolation of a cDNA encoding the human brain serotonin transporter. J. Neural. Transm. Gen. Sect. 91 (1993) 67-72
20. Li L.B., Chen N., Ramamoorthy S., Chi L., Cui X.N., Wang L.C., and Reith M.E. The role of N-glycosylation in function and surface trafficking of the human dopamine transporter. J. Biol. Chem. 279 (2004) 21012-21020
21. Little K.Y., Zhang L., and Cook E. Fluoxetine-induced alterations in human platelet serotonin transporter expression: serotonin transporter polymorphism effects. J. Psychiatry Neurosci. 31 (2006) 333-339
22. 123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry 44 (1998) 1090-1098
23. Marcusson J.O., and Ross S.B. Binding of some antidepressants to the 5-hydroxytryptamine transporter in brain and platelets. Psychopharmacology (Berl) 102 (1990) 145-155
24. Melikian H.E., Ramamoorthy S., Tate C.G., and Blakely R.D. Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition. Mol. Pharmacol. 50 (1996) 266-276
25. Meredith E.J., Chamba A., Holder M.J., Barnes N.M., and Gordon J. Close encounters of the monoamine kind: immune cells betray their nervous disposition. Immunology 115 (2005) 289-295
26. Meredith E.J., Holder M.J., Chamba A., Challa A., Drake-Lee A., Bunce C.M., Drayson M.T., Pilkington G., Blakely R.D., Dyer M.J., Barnes N.M., and Gordon J. The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropics. FASEB J. 19 (2005) 1187-1189
27. Mochizuki H., Amano T., Seki T., Matsubayashi H., Mitsuhata C., Morita K., Kitayama S., Dohi T., Mishima H.K., and Sakai N. Role of C-terminal region in the functional regulation of rat serotonin transporter (SERT). Neurochem. Int. 46 (2005) 93-105
28. Najib A., Pelliccioni P., Gil C., and Aguilera J. Serotonin transporter phosphorylation modulated by tetanus toxin. FEBS Lett. 486 (2000) 136-142
29. Ni W., Thompson J.M., Northcott C.A., Lookingland K., and Watts S.W. The serotonin transporter is present and functional in peripheral arterial smooth muscle. J. Cardiovasc. Pharmacol. 43 (2004) 770-781
30. Ozaslan D., Wang S., Ahmed B.A., Kocabas A.M., McCastlain J.C., Bene A., and Kilic F. Glycosyl modification facilitates homo- and hetero-oligomerization of the serotonin transporter. A specific role for sialic acid residues. J. Biol. Chem. 278 (2003) 43991-44000
31. Pisarchik A., and Slominski A. Molecular and functional characterization of novel CRFR1 isoforms from the skin. Eur. J. Biochem. 271 (2004) 2821-2830
32. Pizzinat N., Girolami J.P., Parini A., Pecher C., and Ordener C. Serotonin metabolism in rat mesangial cells: involvement of a serotonin transporter and monoamine oxidase A. Kidney Int. 56 (1999) 1391-1399
33. Purselle D.C., and Nemeroff C.B. Serotonin transporter: a potential substrate in the biology of suicide. Neuropsychopharmacology 28 (2003) 613-619
34. Qian Y., Melikian H.E., Rye D.B., Levey A.I., and Blakely R.D. Identification and characterization of antidepressant-sensitive serotonin transporter proteins using site-specific antibodies. J. Neurosci. 15 (1995) 1261-1274
35. Qian Y., Galli A., Ramamoorthy S., Risso S., DeFelice L.J., and Blakely R.D. Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J. Neurosci. 17 (1997) 45-57
36. Ramamoorthy S., and Blakely R.D. Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science 285 (1999) 763-766
37. Ramamoorthy S., Bauman A.L., Moore K.R., Han H., Yang-Feng T., Chang A.S., Ganapathy V., and Blakely R.D. Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 2542-2546
38. Ramamoorthy S., Giovanetti E., Qian Y., and Blakely R.D. Phosphorylation and regulation of antidepressant-sensitive serotonin transporters. J. Biol. Chem. 273 (1998) 2458-2466
39. Rothman R.B., and Baumann M.H. Monoamine transporters and psychostimulant drugs. Eur. J. Pharmacol. 479 (2003) 23-40
40. Rothman R.B., Jayanthi S., Wang X., Dersch C.M., Cadet J.L., Prisinzano T., Rice K.C., and Baumann M.H. High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain. Synapse 50 (2003) 233-239
41. Rotondo A., Giannaccini G., Betti L., Chiellini G., Marazziti D., Martin C., Lucacchini A., and Cassano G.B. The serotonin transporter from human brain: purification and partial characterization. Neurochem. Int. 28 (1996) 299-307
42. Rudd M.L., Nicolas A.N., Brown B.L., Fischer-Stenger K., and Stewart J.K. Peritoneal macrophages express the serotonin transporter. J. Neuroimmunol. 159 (2005) 113-118
43. Rudnick G., and Wall S.C. The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 1817-1821
44. Serafeim A., Grafton G., Chamba A., Gregory C.D., Blakely R.D., Bowery N.G., Barnes N.M., and Gordon J. 5-Hydroxytryptamine drives apoptosis in biopsylike Burkitt lymphoma cells: reversal by selective serotonin reuptake inhibitors. Blood 99 (2002) 2545-2553
45. Serafeim A., Holder M.J., Grafton G., Chamba A., Drayson M.T., Luong Q.T., Bunce C.M., Gregory C.D., Barnes N.M., and Gordon J. Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells. Blood 101 (2003) 3212-3219
46. Shaw G., Morse S., Ararat M., and Graham F.L. Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J. 16 (2002) 869-871
47. Shively C.A., Mirkes S.J., Lu N.Z., Henderson J.A., and Bethea C.L. Soy and social stress affect serotonin neurotransmission in primates. Pharmacogenomics J. 3 (2003) 114-121
48. Tate C.G., and Blakely R.D. The effect of N-linked glycosylation on activity of the Na(+)- and Cl(-)-dependent serotonin transporter expressed using recombinant baculovirus in insect cells. J. Biol. Chem. 269 (1994) 26303-26310
49. Tate C.G., Haase J., Baker C., Boorsma M., Magnani F., Vallis Y., and Williams D.C. Comparison of seven different heterologous protein expression systems for the production of the serotonin transporter. Biochim. Biophys. Acta 1610 (2003) 141-153
50. Torres G.E., Gainetdinov R.R., and Caron M.G. Plasma membrane monoamine transporters: structure, regulation and function. Nat. Rev., Neurosci. 4 (2003) 13-25
51. Tsao C.W., Lin Y.S., Cheng J.T., Chang W.W., Chen C.L., Wu S.R., Fan C.W., and Lo H.Y. Serotonin transporter mRNA expression is decreased by lamivudine and ribavirin and increased by interferon in immune cells. Scand. J. Immunol. 63 (2006) 106-115
52. Wade P.R., Chen J., Jaffe B., Kassem I.S., Blakely R.D., and Gershon M.D. Localization and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract. J. Neurosci. 16 (1996) 2352-2364
53. Wang X., Baumann M.H., Xu H., Morales M., and Rothman R.B. (+/-)-3,4-Methylenedioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membrane. J. Pharmacol. Exp. Ther. 314 (2005) 1002-1012
54. Wersinger C., Rusnak M., and Sidhu A. Modulation of the trafficking of the human serotonin transporter by human alpha-synuclein. Eur. J. Neurosci. 24 (2006) 55-64
55. Xie T., Tong L., McLane M.W., Hatzidimitriou G., Yuan J., McCann U., and Ricaurte G. Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines. Neuropsychopharmacology 31 (2006) 2639-2651
56. Zhou F.C., Xu Y., Bledsoe S., Lin R., and Kelley M.R. Serotonin transporter antibodies: production, characterization, and localization in the brain. Brain Res. Mol. Brain Res. 43 (1996) 267-278